1. Introduction {#sec1}
===============

In 2015, about 5.9 million under-5 death occurred [@bib1], from 2 to 7 million have seen in the neonatal period \[[@bib1], [@bib2]\]. Of these, approximately 7000 newborns die every day, which accounted for 47% of all child deaths under the age of 5-years [@bib2]. In general, about 99% of neonatal deaths occur in lower-income and middle-income countries. The remaining 1% of death was from resource-rich nations, and deaths in these countries did not attract sufficient attention from researchers, policy-makers and other key stakeholders. Indeed, many of them happen at home and were often unrecorded [@bib3]. Conventionally, an estimated of 5.29--8.73 million disability-adjusted life years are lost annually in Sub-Sahara due to neonatal sepsis [@bib4].

Sepsis is a major cause of mortality in the first month of life. Overall sepsis causes for 6.8% under-5 mortality from 2000--2015 [@bib1]. The most common (81%) isolated bacteria were gram-negative [@bib5]. A report showed that the incidence of neonatal sepsis was about 20.5%. Of these, *Staphylococcus aureus* accounted for the highest percentage (60%) followed by *Klebsiella pneumonia* (23%) [@bib6]. On the other hand, gram-negative bacteria accounted for 78.9% of all isolates and were the only organisms encountered in early onset sepsis [@bib7]. The incidence of neonatal sepsis was 10.3 per 100 admissions, which was based on blood culture-positive results for 196 out of 236 neonates [@bib8]. Other report revealed that about 65% had presented with early onset neonatal sepsis and 22.4% of them had culture-proven sepsis [@bib7]. Studies in Ethiopia showed that the prevalence of neonatal sepsis was 77.9% [@bib9], 76.8% [@bib10], 72.9% [@bib11], 46.6% [@bib12].

Although a systematic review and meta-analysis study was conducted in high and middle-income countries [@bib13], there is no study conducted in lower-income countries. Therefore, this systematic review and meta-analysis study aimed to address this gap in the literature by determining the pooled prevalence of neonatal sepsis in developing countries.

2. Main text {#sec2}
============

2.1. Methods {#sec2.1}
------------

### 2.1.1. Eligibility criteria {#sec2.1.1}

#### 2.1.1.1. Inclusion criteria {#sec2.1.1.1}

•All studies related to neonates either admitted in the hospital or community-based studies within the neonatal period of life in African, Asian and Latin America was included in the study. These developing countries were Nigeria \[[@bib7], [@bib14], [@bib15], [@bib61]\], Nepal \[[@bib16], [@bib17], [@bib18]\], Tanzania [@bib19], Ethiopia \[[@bib9], [@bib10], [@bib12], [@bib20], [@bib21]\], Egypt \[[@bib22], [@bib23]\], Bangladesh [@bib24], Sudan \[[@bib25], [@bib26]\], Indonesia [@bib27], Zambia [@bib28], India \[[@bib29], [@bib30], [@bib31], [@bib32], [@bib33]\] Sri Lanka [@bib34], Uganda [@bib35], Haiti [@bib36], Kenya [@bib37], Ghana [@bib38], South Africa [@bib8], Cameroon [@bib39], Brazil [@bib40], Mexico [@bib41], Jamaica [@bib42] and Nepal \[[@bib17], [@bib18]\].•Publication year: All articles published from 2005 to 2018 are used for systematic review and meta-analysis.•Design: All observational studies which assessed the neonatal sepsis in developing countries are included in the study.•Publication status: All published literature were included in the study.•Language: Only articles published literature reported in the English language were included.

#### 2.1.1.2. Exclusion criteria {#sec2.1.1.2}

Studies conducted by systematic review and meta-analysis and studies with methodologically unclear were excluded from this study. Also, articles published other than the English language were excluded from this study because this might cause poor understanding and translation bias.

#### 2.1.1.3. Study design, information sources and search strategy {#sec2.1.1.3}

This systematic review and meta-analysis method was used by considering the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [@bib43]. We used google and google scholar search engines, electronic databases (Pub Med, CINAHL Plus, Hinari Access to Research for Health programme) and different journal sites (Africa Journals Online, Global Health journal, Academic Search, Directory of Open Access Journals). This study was conducted from October first, 2018 to 5 November 2018. The searching terms were pre-defined to allow a comprehensive search strategy which included in all fields within records and Medical Subject Headings (MeSH terms) were used to help expand the search in advanced PubMed search. We also used Boolean operator (within each axis we combined keywords with the "OR" operator and we then linked the search strategies for the two axes with the "AND" operator). The key terms used to search were \"newborn OR infant OR infancy AND sepsis OR infection AND developing AND countries\". Moreover, the cross-reference list was used to retrieve other related articles. Endnote reference manager software was utilized to collect and organize search outcomes and to remove duplication.

#### 2.1.1.4. Study selection {#sec2.1.1.4}

After a full abstract has been retrieved and reviewed, and the studies which meet the inclusion criteria would then be obtained and reviewed in full. The review process has been done by two reviewers, this helps to increase the reliability of the data selected. The disparity between these reviewers was resolved with a third reviewer (MM) whenever appropriate. Finally, we saved all reviewed studies that fulfill the inclusion criteria.

#### 2.1.1.5. Data extraction {#sec2.1.1.5}

The data extraction was done by two researchers using a data extraction table. This data extraction table includes the authors\' name, publication year, study design, sample size, study participants, response rate, study methods, study prevalence, illegibility criteria, and the searching terms. The definition of the neonatal period was used to extract the data \"regardless of gestational age, the neonatal period begins at birth and includes the first month of life \[[@bib17], [@bib18]\]".

#### 2.1.1.6. Quality assessment and data collection {#sec2.1.1.6}

Studies were eligible for data extraction when they met the Newcastle-Ottawa Scale tool criteria in terms of enough sample size, clarity of research aims, appropriateness of design, recruitment, data collection, analysis and reporting of findings. When there was unclear abstract whether a citation is relevant or not, it was excluded for full-text retrieval. Then the full text of potentially eligible papers against the inclusion criteria was assessed. The relevance of the reviewed studies was checked based on their topic, objectives, and methodology. A preliminary assessment was made and some articles were excluded from the first step based on their topics and abstracts. After reviewing the full article, the score was given based on the Newcastle-Ottawa Scale [@bib44].

#### 2.1.1.7. Publication bias and heterogeneity {#sec2.1.1.7}

Statistical heterogeneity across the studies was evaluated by using I^2^ statistic and the continuous and categorical Meta-regression analysis was performed to determine the potential sources of heterogeneity. The Egger\'s and Begg\'s tests were applied to evaluate the potential publication biases of the studies. The random effect model was used to examine statistically significant heterogeneity and the trim and fill analysis was done to assess the presence of publication bias.

#### 2.1.1.8. Outcome of interest {#sec2.1.1.8}

The outcome of interest was the pooled prevalence of sepsis among neonates in developing countries. This pooled prevalence was measured as the number of neonates with sepsis divided by the number of patients in a study multiplied by 100.

#### 2.1.1.9. Statistical analysis {#sec2.1.1.9}

We planned to analyze the pooled prevalence of neonatal sepsis using STATA software version 11. A forest plot was analyzed using Meta-regression analysis and significant heterogeneity was found within studies. A subgroup analysis was done to determine the heterogeneity within the regions by using the random-effects model. Begg\'s and Egger\'s tests were done to observe a publication bias. These Begg\'s and Egger\'s test with P \< 0.05 were considered as significant publication bias. Finally, publication bias was assessed using the trim and filled analysis method.

2.2. Results {#sec2.2}
------------

### 2.2.1. Study selection {#sec2.2.1}

A total of 1093 Records were identified through the electronic database, search engines, and journal lists. Searching was conducted by the principal investigator and the co-author. From the total identified articles, 486 articles were excluded since they are duplicated. About 568 articles were removed by screening using their titles and abstracts. Three articles were excluded after using full-text review with the reason that the outcomes of the articles were not clear for researchers \[[@bib10], [@bib45], [@bib46]\]. Finally, 36 articles fit with our study objectives ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Flow diagram showing the procedure of screening studies for meta-analysis.Fig. 1

### 2.2.2. Study characteristics {#sec2.2.2}

The maximum sample size obtained during searching was 34362 in India with retrospective study design [@bib29]and the minimum sample size was 119 in Sudan along with cross-sectional study design [@bib26]. The mean sample size of the study was 2226.8. Except one, all articles included in this study had 100% response rates. The majority (75.7%) of the studies were confirmed the neonatal sepsis through culture and the remaining articles diagnosis was settled using clinical signs and symptoms ([Table 1](#tbl1){ref-type="table"}).Table 1Characteristics of studies in Meta analysis of prevalence of neonatal sepsis in Africa, Asia, and Latin America.Table 1AuthorsYearStudy designNResponse rate (%)DiagnosisCountriesPNS (95% CI)Culture/clinical%Arowosegbe et al. [@bib8]2017Cross-sectional180100Culture positive43.5Nigeria47.2 (39.65,54.75)Thapa B et al. [@bib17]2014Cross-sectional300100Culture positive17Nepal31.4 (24.64,38.16)Jabiri A et al. [@bib7]2016Cross-sectional220100Clinical\-\--Tanzania77.9 (69.36,86.44)Getabelew A et al. [@bib11]2017Cross-sectional244100Clinical\-\--Ethiopia8.6 (4.38,12.82)Medhat H et al. [@bib18]2017Retrospective cohort1023100Clinical8.6Egypt17.5 (11.89,23.11)Raha BK et al. [@bib19]2014Cross-sectional720100Culture positive8.9Bangladesh36 (28.98,43.02)Kheir AEM et al. [@bib12]2014Cross-sectional354100Culture positive61.3Sudan47.8 (30.67,44.92)Hasibuan BS [@bib22]2018Cross-sectional626100Culture Positive24.6Indonesia46.6 (39.07,54.13)Kabwe M et al. [@bib21]2016Cross-sectional31391.5Culture positive33Zambia43.5 (36.11,50.89)Panigrahi P et al [@bib22]2017Prospective cohort842100Culture positive100India34 (27.09,40.91)Babiker W et al. [@bib16]2018Cross-sectional119100Culture positive37.8Sudan76 (68.29,85.31)G/eyesus T et al. [@bib61]2017Cross-sectional251100Culture positive46.6Ethiopia67.9 (59.63,76.17)Peterside O et al [@bib23]2015Retrospective cohort233100Culture positive43.5Nigeria21.8 (15.76,27.84)Sundarm V et al. [@bib15]2009Retrospective cohort34362100Culture positive4.3India72.2 (63.8,80.6)Agrawal A et al. [@bib24]2018Cross-sectional850100Culture positive5.06India26.7 (20.26,33.14)Perera KSY et al. [@bib25]2018Case control3482100Culture positive2Sri Lanka45.9 (38.4,58.4)Verma P et al. [@bib26]2015Prospective cohort3130100Culture positive7.6India21.9 (15.85,27.95)Shobowale OE et al. [@bib27]2016Cross-sectional250100Culture positive34Nigeria10.3 (5.73,14.87)Gebremedhin D ea al [@bib12].2016Case control234100Clinical\-\--Ethiopia34.7 (22.75,41.65)Demisse AG et al. [@bib28]2017Cross-sectional769100Clinical\-\--Ethiopia38.1 (30.97,45.23)John B et al. [@bib29]2015Cross-sectional174100Culture positive21.8Uganda79.1 (70.53,87.67)Boulos A et al. [@bib30]2017Retrospective cohort1292100Culture positive74Haiti16 (10.57,21.43)Minyahil AW et al. [@bib31]2014Cross-sectional306100Clinical\-\--Ethiopia?37.1 (30.04,44.20)Kumar A et al. [@bib32]2010Cross-sectional310100Culture positive26.7Kenya8.9 (4.62,13.18)El-Din ERS [@bib33]2015Retrospective cohort778100Clinical\-\--Egypt24.6 (18.32,30.88)Labi A-K et al. [@bib34]2016Retrospective cohort8025100Culture positive21.9Ghana10 (5.49,14.51)Shah AJ et al. [@bib35]2012Prospective cohort190100Culture Positive31.6India4.3 (1.46,7.20)Lebea MM et al. [@bib9]2017Retrospective cohort1903100Culture positive10.3South Africa5 (1.88,8.24)Chiabi A et al. [@bib36]2011Prospective cohort628100Culture positive9.6Cameroon4.6 (1.61,7.59)Ameyaw E et al. [@bib37]2017Cross-sectional1580100Clinical\-\--Ghana7.6 (3.62,11.58)Emmanuel EN et al. [@bib38]2016Cross-sectional269100Clinical\-\--Cameroon31.6 (3.62,11.58)Dal-Bó K et al. [@bib39]2012Retrospective cohort239100Culture positive27.1Brazil12.6 (7.63,17.57)Leal YA et al. [@bib40]2012Retrospective cohort11,790100Culture positive16.9Mexico20.5 (14.58,26.42)BELL Y et al. [@bib41]2005Retrospective cohort4702100Culture positive2.9Jamaica54.8 (46.95,62.65)Ansari S et al. [@bib42]2015Cross-sectional918100Culture positive12.6Nepal45.8 (38.30,53.30)Pokhrel B et al. [@bib43]2018Retrospective cohort336100Culture positive20.5Nepal4.3 (1.44,7.16)Olatunde OE et al. [@bib44]2016Prospective cohort450100Culture positive16Nigeria2.9 (0.81,4.99)

### 2.2.3. Prevalence of neonatal sepsis and heterogeneity {#sec2.2.3}

The overall pooled prevalence was 29.92 with (95% CI 23.95, 35.90). The overall heterogeneity of this study was I^2^ = 98.1% (P-value = 000) ([Fig. 2](#fig2){ref-type="fig"}). The study was sub-group into three regions which are Africa, Asia, and Latin America. The high heterogeneity has shown within regions. The regional prevalence were 38.56, 14.68 and 26.48 in Africa, Asia, and Latin America, respectively. Heterogeneities in Africa Asia and Latin America were 97.3%, 94%, and 98.9 %, respectively ([Fig. 3](#fig3){ref-type="fig"}). Studies in Ethiopia have shown that there is a significant heterogeneity (coefficient = 90, P-value = 0.025) ([Table 2](#tbl2){ref-type="table"}).Fig. 2Forest plot, showing the results from a cumulative meta-analysis of 36 studies to determine the pooled prevalence of neonatal sepsis in developing countries.Fig. 2Fig. 3Subgroup analysis of the study by its regions.Fig. 3Table 2Meta-regression test on selected variables to identify source of heterogenity among studies.Table 2VariablesCoefficientP-valueYear of study0.480.15Sample size0.250.17**Institutions**District hospital-49.10.33General-36.80.34Referral-54.60.28Tertiary care hospital-54.30.25Tertiary-51.50.30Community-48.10.38**Study design**Case control35.90.27Cross-section16.30.33Retrospective8.30.63**Region**Bangladesh23.90.52Brazil83.60.12Cameroon93.60.06Egypt680.20Ethiopia900.025Ghana66.70.16Haiti95.60.09India52.60.26Indonesia57.40.26Jamaica43.50.37Mexico42.10.41Nepal57.60.20Nigeria72.40.12South Africa50.90.30Sudan58.50.20Tanzania64.20.21Uganda630.35Zambia68.80.18Kenya59.50.24

### 2.2.4. Risk of bias within studies {#sec2.2.4}

The Begg\'s test has not shown a significant publication bias with (P-value\>0.05). The Egger\'s test showed that there is a significant publication bias with P-value 0.001. The funnel plot test has shown that there are asymmetric plots. These plots indicated that there is a significant publication bias in which the majority of the plots were placed between 0 and +5 ([Fig. 4](#fig4){ref-type="fig"}). However, after a trim and filled analysis, publication bias has not been shown ([Fig. 5](#fig5){ref-type="fig"}).Fig. 4The funnel plots which are asymmetric and showed there are possible publication bias.Fig. 4Fig. 5Filled funnel plot which has no shown publication bias.Fig. 5

2.3. Discussion {#sec2.3}
---------------

This systematic review and meta-analysis study was conducted to determine the pooled prevalence of neonatal sepsis in developing countries. We have found consistent evidence of higher levels of neonatal infection within 28 days with the pooled prevalence of 29.92% (95%CI 23.95, 35.90) which shows a major problem of the developing countries. This finding was appreciably higher than other studies conducted elsewhere 17% in China [@bib47], 7.6% in India [@bib48] and the prevalence of early-onset neonatal sepsis which was confirmed by the laboratory was 17.2% [@bib49]. Even if the health care units advanced recently, sepsis remained the major causes of morbidity and mortality for neonates [@bib50] and greater than 40% of under-five deaths occur in the neonatal period, resulting in 3.1 million newborn deaths each year globally [@bib51]. The neonatal morbidity was predominantly higher in low and middle-income countries [@bib52] particularly, in Africa and it is the third common cause of death \[[@bib53], [@bib54]\]. This difference could be due to a lack of well-established the health care system since the majority of studies have been taken in Sub Saharan Africa and another part of developing regions.

The prevalence of this study is consistent with the reports by Shah AJ et al [@bib55] 31.57%, Jabiri A et al. [@bib19], which accounted 31.57% and 31.4%, respectively. This high magnitude is the major public health issue in developing countries (Sub Saharan Africa), an estimated magnitude of range from 380 000--2 000 000 annual cases and 270 000 annual associated deaths [@bib56]. Sepsis is one of the three most common causes of neonatal deaths globally [@bib57]. Most infection in the neonatal period occurs in low and middle-income countries due to poor hygiene and suboptimal practices for infection control [@bib58]. This can be the future agenda of the developing countries.

Majority of studies included in our study were confirmed through blood or cerebrospinal fluid culture \[[@bib8], [@bib14], [@bib16], [@bib18], [@bib19], [@bib24], [@bib26], [@bib27], [@bib29], [@bib33], [@bib36], [@bib38], [@bib39], [@bib42], [@bib48], [@bib55], [@bib59], [@bib60]\] and others were neonatal sepsis diagnosed using clinical signs and symptoms \[[@bib9], [@bib12], [@bib20]\]. Consequently, studies with neonatal sepsis diagnosed using clinical signs and symptoms of infection may have a low magnitude of the association compared to studies confirmed with culture or laboratory test. This is because clinical diagnosis is less specific to settle the definite diagnosis of neonatal sepsis. In the other way diagnosis of neonatal sepsis in the early onset period, the result may undermine the true risk of the infection since the sensitivity of the result depends on the specimen collection process [@bib61].

This systematic and Meta-analysis revealed that there was a significant heterogeneity throughout the studies within intern-regional and intra region. The source of heterogeneity could be studies conducted in Ethiopia because the Meta-regression of studies in Ethiopia has a significant P- value less than 0.05. Other reports have also supported that they have heterogeneity between studies [@bib49] and consider this heterogeneity existed between studies given the various definitions of laboratory-confirmed and clinical signs of infection, as well as for colonization and risk factors \[[@bib62], [@bib63], [@bib64]\].

Bacterial pathogens such as *Klebsiella, CoNS*, and *S. aureus* were the common cause of neonatal infections in the developing countries \[[@bib7], [@bib8], [@bib14], [@bib16], [@bib17], [@bib18], [@bib19], [@bib24], [@bib26], [@bib27], [@bib29], [@bib30], [@bib33], [@bib36], [@bib38], [@bib39], [@bib42], [@bib48], [@bib55], [@bib59], [@bib60]\]. Congruently, it is supported by reports of the newborn problem in lower and middle-income countries \[[@bib65], [@bib66]\] and the evidence from other systematic review showed that *Klebsiella* species, *E. coli,* and *S. aureus* were the major cause of neonatal infection during the neonatal period [@bib67]. This may be due to the susceptibility of neonatal population, lack of consensus in the definitions and pathogen variability between different regions which affect the development of clinical trials and practice guidelines [@bib65].

The strength of this study was included different regions of lower and middle-income countries and we used extensive searching strategies to minimize the chance of missing the relevant articles and literature. For this systematic review and meta-analysis, using only articles reported in the English language was our limitation. Also, publication bias is the limitations of this study.

3. Conclusion {#sec3}
=============

We concluded that the prevalence of neonatal sepsis was significantly higher among developing countries. The developing countries accounted for a third of the neonatal sepsis. Majority of neonatal sepsis were in Africa region. Bacteria is the leading cause of neonatal sepsis. Heterogeneity among studies was reported and can be existed between studies given the various definitions of laboratory-confirmed and clinical signs of infection, as well as for colonization and risk factors. Despite various countries have established a possible prevention and treatment mechanisms, neonatal sepsis is the major problem of lower and middle-income countries.
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